The burden of atrial fibrillation on the hospital sector in Canada

Daria J O'Reilly1, Robert B Hopkins, Jeff S Healey

  • 1Programs for Assessment of Technology in Health (PATH) Research Institute, St Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada. oreilld@mcmaster.ca

Insights

Atrial fibrillation (AF) significantly burdens Canadian hospitals, costing $815 million annually. Most costs stem from AF-related hospitalizations and comorbidities, not direct AF treatments.

Area of Science:

  • Health Economics
  • Cardiology
  • Public Health

Background:

  • Atrial fibrillation (AF) is a prevalent condition necessitating frequent acute hospital care.
  • The economic impact of AF on Canadian hospital care has not been previously quantified.

Purpose of the Study:

  • To estimate the total cost of hospital-based care attributable to atrial fibrillation in Canada.

Main Methods:

  • Utilized national administrative databases from 2007-2008, including hospital admissions, day surgeries, and ambulatory care.
  • Calculated costs by applying average cost per weighted case and resource intensity weights, adding fees for procedures and interventions.
  • Included records with AF as primary diagnosis, atrial flutter, or AF with comorbidities.

Main Results:

  • In 2007-2008, AF accounted for $815 million in Canadian hospital costs (2010 CAD).
  • Hospitalizations represented the largest cost component ($710 million), with comorbidities driving 69% ($558 million) of acute care expenses.
  • Emergency department visits and same-day surgical procedures added $73 million and $32 million, respectively.

Conclusions:

  • Atrial fibrillation imposes a substantial financial burden on Canada's acute care hospital sector.
  • The majority of AF-related hospital costs are associated with managing AF's consequences and comorbidities.
  • Direct treatment costs for AF constitute a relatively small portion of the overall expenditure.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...